Duncan Learmouth
Director/Board Member at Burroughs Wellcome & Co. Ltd.
Profile
Duncan Learmouth is currently a Director at Burroughs Wellcome & Co. Ltd.
He previously worked as a Non-Executive Chairman at Unilever Consumer Care Ltd.
from 2012 to 2013.
He also worked as a Director at ViiV Healthcare Ltd.
and as a Senior VP-Developing Countries & Market Access at GSK Plc from 2013 to 2014.
Duncan Learmouth active positions
| Companies | Position | Start |
|---|---|---|
| Burroughs Wellcome & Co. Ltd. | Director/Board Member | - |
Former positions of Duncan Learmouth
| Companies | Position | End |
|---|---|---|
| UNILEVER CONSUMER CARE LIMITED | Chairman | 29/10/2013 |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Director/Board Member | - |
| GSK PLC | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GSK PLC | Health Technology |
| UNILEVER CONSUMER CARE LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
| Burroughs Wellcome & Co. Ltd. |
- Stock Market
- Insiders
- Duncan Learmouth
